meta_pixel
Tapesearch Logo
Log in
This Week in Cardiology

Dec 01 2023 This Week in Cardiology

This Week in Cardiology

Medscape Podcasts

Medicine, Science, Health & Fitness

4.9963 Ratings

🗓️ 1 December 2023

⏱️ 28 minutes

🧾️ Download transcript

Summary

More from AHA including SGLT2 inhibitors, blood transfusion after MI; cracks in the armor of Factor XI inhibitors; and renal denervation are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

https://www.medscape.com/twic

I. DAPA MI

Potential Dapagliflozin Benefit Post-MI Is Not a 'Mandate'

https://www.medscape.com/s/viewarticle/998378

- NEJM Evidence: Dapagliflozin After MI https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300286

II. Blood Transfusion Strategy Post MI

In MI With Anemia, Results May Favor Liberal Transfusion: MINT

https://www.medscape.com/viewarticle/998376

- MINT NEJM -- https://www.nejm.org/doi/full/10.1056/NEJMoa2307983

- REALITY https://jamanetwork.com/journals/jama/fullarticle/2776201

- PROTECTED TAVR - https://www.nejm.org/doi/full/10.1056/NEJMoa2204961

III. FACTOR XI

Impressive Bleeding Profile With Factor XI Inhibitor in AF: AZALEA

https://www.medscape.com/viewarticle/998418

Asundexian Phase 3 AF Study Halted for Lack of Efficacy

https://www.medscape.com/viewarticle/998665

- Abelacimab for VTE https://www.nejm.org/doi/full/10.1056/NEJMoa2105872

IV. Renal Denervation

FDA Panel Split on Efficacy of Spyral Renal Denervation

https://www.medscape.com/viewarticle/995800

FDA OKs Symplicity Renal Denervation System for Hypertension

https://www.medscape.com/viewarticle/998664

- SPYRAL HTN OFF MED  -- https://doi.org/10.1016/S0140-6736(20)30554-7

- SPRYAL HTN On Meds (Pilot Lancet 2018 ) https://doi.org/10.1016/S0140-6736(18)30951-6

- SPRYAL HTN ON Meds (Expansion Pilot) https://doi.org/10.1016/j.jacc.2023.08.045

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

https://www.medscape.com/features/public/machine

The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington

Questions or feedback, please contact news@medscape.net

Transcript

Click on a timestamp to play from that location

0:00.0

You're listening to this week in cardiology from the heart

0:03.4

org medscape cardiology this podcast is intended for health care

0:07.6

professionals only any views expressed are the presenters own and do not

0:11.2

necessarily reflect the views of WebMD or Medscape.

0:15.1

You can now access the latest in medical news on your Amazon Alexa-enabled device.

0:19.9

Join me, Perry Wilson, every weekday morning for Medscape Medical Minute where I highlight the top

0:24.7

medical stories of the day.

0:26.5

To add Medscape Medical Minute to your flash briefing, search for Medscape Medical Minute on Amazon

0:31.3

and click enable or open the Amazon Alexa app go to skills

0:34.7

search for Medscape Medical Minute and click enable then say Alexa what's the

0:40.1

news or Alexa what's my flash briefing I hope you'll join us.

0:44.0

Hi everyone this is John Mandrola from the Heart.org medscape and this is this

0:50.0

week in cardiology for December 1st, 2023. This week we'll have more from the

0:56.1

AHA. This includes SGLT 2 inhibitors after MI, blood transfusion

1:02.0

strategies after MI. I. A crack in the armor of factor 11

1:06.9

inhibitors and more on renal denervation. First up is the DAPA M.I trial. This was presented at AHA. The SGLT 2 inhibitor class of drugs have as positive,

1:20.0

both tons of empirical data and they're also easy to use.

1:24.0

In chronic kidney disease, and diabetes, and heart failure, there are clear benefits.

1:29.0

Now we can debate cost efficacy, but there are surely benefits. What about in post-MI patients?

1:36.7

Swedish investigators' first author, Stefan James, tested the idea of adding Dabaglip

1:41.7

Wilson to patients after an MI that either left the patient

1:45.9

with a Q wave on the EKG or mild left intrigular dysfunction.

...

Please login to see the full transcript.

Disclaimer: The podcast and artwork embedded on this page are from Medscape Podcasts, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Medscape Podcasts and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.

Copyright © Tapesearch 2026.